Alpine eyes $100M capital infusion; Bob Duggan lends $65M to cosmetics company-turned-biotech
Alpine Immune Sciences is looking to reel in $100 million by Friday by selling 13.6 million shares at $7.35 a pop, the biotech said late …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
